[1] Chertow G M, Levy E M, Hammermeister K E, et al. Independent association between acute renal failure and mortality following cardiac surgery[J]. Am J Med, 1998,104(4):343-348.[2] Kuitunen A, Vento A, Suojaranta-Ylinen R, et al. Acute renal failure after cardiac surgery: evaluation of the RIFLE classification[J]. Ann Thorac Surg, 2006,81(2):542-546.[3] Reddy N P, Ravi K P, Dhanalakshmi P, et al. Epidemiology, outcomes and validation of RIFLE and AKIN criteria in acute kidney injury(AKI) in critically ill patients: Indian perspective[J]. Ren Fail, 2014,36(6):831-837.[4] Gaffney A M, Sladen R N. Acute kidney injury in cardiac surgery[J]. Curr Opin Anaesthesiol, 2015,28(1):50-59.[5] Swaminathan M, Hudson C C, Phillips-Bute B G, et al. Impact of early renal recovery on survival after cardiac surgery-associated acute kidney injury[J]. Ann Thorac Surg, 2010,89(4):1098-1104.[6] D'Onofrio A, Cruz D, Bolgan I, et al. RIFLE criteria for cardiac surgery-associated acute kidney injury: risk factors and outcomes[J]. Congest Heart Fail, 2010,16 Suppl 1:S32-S36.[7] 蒋波,姜利,席修明.不同生物学标志物对感染性急性肾损伤肾脏替代治疗的预测作用[J].首都医科大学学报,2013,34(2):187-190.[8] Meinel F G, De Cecco C N, Schoepf U J, et al. Contrast-induced acute kidney injury: definition, epidemiology, and outcome[J]. Biomed Res Int, 2014,2014:859328.[9] Mishra J, Ma Q, Prada A, et al. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury[J]. J Am Soc Nephrol, 2003,14(10):2534-2543.[10] Mishra J, Dent C, Tarabishi R, et al. Neutrophil gelatinase-associated lipocalin(NGAL) as a biomarker for acute renal injury after cardiac surgery[J]. Lancet, 2005,365(9466):1231-1238.[11] Ad-hoc Working group of ERBP, Fliser D, Laville M, Covic A, et al. A European Renal Best Practice(ERBP) position statement on the Kidney Disease Improving Global Outcomes(KDIGO) clinical practice guidelines on acute kidney injury: part 1: definitions, conservative management and contrast-induced nephropathy[J]. Nephrol Dial Transplant, 2012,27(12):4263-4272.[12] Chertow G M, Burdick E, Honour M, et al. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients[J]. J Am Soc Nephrol, 2005,16(11):3365-3370.[13] Alabbas A, Campbell A, Skippen P, et al. Epidemiology of cardiac surgery-associated acute kidney injury in neonates: a retrospective study[J]. Pediatr Nephrol, 2013,28(7):1127-1134.[14] Aitken E, Carruthers C, Gall L, et al. Acute kidney injury: outcomes and quality of care[J]. QJM, 2013,106(4):323-332.[15] Schetz M, Bove T, Morelli A, et al. Prevention of cardiac surgery-associated acute kidney injury[J]. Int J Artif Organs, 2008,31(2):179-189.[16] Cruz D N, Ronco C, Katz N. Neutrophil gelatinase-associated lipocalin: a promising biomarker for detecting cardiac surgery-associated acute kidney injury[J]. J Thorac Cardiovasc Surg, 2010,139(5):1101-1106.[17] Giasson J, Li G H, Chen Y. Neutrophil gelatinase-associated lipocalin(NGAL) as a new biomarker for non acute kidney injury(AKI) diseases[J]. Inflamm Allergy Drug Targets, 2011,10(4):272-282.[18] Steiner M S, Goldman S M, Fishman E K, et al. The natural history of renal angiomyolipoma[J]. J Urol, 1993,150(6):1782-1786.[19] Liebetrau C, Dorr O, Baumgarten H, et al. Neutrophil gelatinase-associated lipocalin(NGAL) for the early detection of cardiac surgery associated acute kidney injury[J]. Scand J Clin Lab Invest, 2013,73(5):392-399. |